Clinical studies of alpha-interferons in chronic myelogenous leukemia.
Talpaz
M
M
Department of Clinical Immunology and Biological Therapy, M.D. Anderson Hospital and Tumor Institute, Houston, Texas.
D002986:Clinical Trials as Topic; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000150:complications / Q000235:genetics / Q000628:therapy*; D010677:Philadelphia Chromosome; D011994:Recombinant Proteins / Q000627:therapeutic use; D013922:Thrombocytosis / Q000150:complications
D007370:Interferon Type I; D011994:Recombinant Proteins